Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study

BACKGROUND: An established treatment strategy for asymptomatic pulmonary embolism (PE) or deep vein thrombosis (DVT) remains uncertain in Japan; therefore, in this study, we clarify the characteristics and outcomes of symptomatic compared to asymptomatic patients with PE or DVT. METHODS: This prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Migita, Shohei, Okumura, Yasuo, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Ikeda, Takanori, Mo, Makoto, Yamazaki, Tsutomu, Hirayama, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440934/
https://www.ncbi.nlm.nih.gov/pubmed/37599351
http://dx.doi.org/10.1186/s12959-023-00528-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440934/
https://www.ncbi.nlm.nih.gov/pubmed/37599351
http://dx.doi.org/10.1186/s12959-023-00528-w

Ejemplares similares